After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Fierce Pharma
JUNE 7, 2023
At the BIO International Convention, Biogen CEO Chris Viehbacher registered severe criticism of the IRA and said his company was considering filing its own lawsuit. . | Merck has filed a lawsuit seeking to overturn drug-pricing measures in the Inflation Reduction Act (IRA).
Let's personalize your content